IL33 and neoplasm: We previously demonstrated in a Lewis lung carcinoma (3LL) model that IL‐33 induces the death of ST2L‐positive weak metastatic cells but not of ST2L‐negative highly metastatic cells, suggesting the selection of highly metastatic cells within the tumor microenvironment [20].